StockMacro
Company, fund or insider

Help

Menu

Cadre

$29.45 -5.2% in 6 monthsMarket cap $1.3B

CDRE on XNYS, Health Care, Cadre Holdings, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue up 30% to $202.9M last quarter, but shares are down 25% in a year.

  • GoodFederal contracts reached $22.3M, up from $78K a year earlier
  • BadShort interest up 14% on the latest report, now 5.0% of shares

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments - the Product segment, which is comprised of components that manufacture and sell products, and the Distribution segment, which is comprised of business that serves as a one-stop shop for law enforcement agencies that sells goods produced by the Product segment, as well as other third-party products.

Industry
Orthopedic, prosthetic & surgical appliances & supplies (Health Care)
Employees
2,533
Website
cadre-holdings.com
Listed
NYSE, US
Last results
4 Nov 2026
Next results
expected around 9 Mar 2027 (an estimate: a year ago it reported on 10 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $202.9M, net income $16.0M.
Quarter to 31 Dec 2021: revenue $103.5M, net income $4.3MQuarter to 31 Dec 2021: revenue $103.5M, net income $4.3MQuarter to 31 Mar 2022: revenue $104.4M, net income -$10.2MQuarter to 31 Mar 2022: revenue $104.4M, net income -$10.2MQuarter to 30 Jun 2022: revenue $118.2M, net income $4.4MQuarter to 30 Jun 2022: revenue $118.2M, net income $4.4MQuarter to 30 Sep 2022: revenue $111.6M, net income $4.9MQuarter to 30 Sep 2022: revenue $111.6M, net income $4.9MQuarter to 31 Dec 2022: revenue $123.6M, net income $6.6MQuarter to 31 Dec 2022: revenue $123.6M, net income $6.6MQuarter to 31 Mar 2023: revenue $111.7M, net income $7.0MQuarter to 31 Mar 2023: revenue $111.7M, net income $7.0MQuarter to 30 Jun 2023: revenue $121.1M, net income $11.0MQuarter to 30 Jun 2023: revenue $121.1M, net income $11.0MQuarter to 30 Sep 2023: revenue $125.1M, net income $11.1MQuarter to 30 Sep 2023: revenue $125.1M, net income $11.1MQuarter to 31 Dec 2023: revenue $124.6M, net income $9.6MQuarter to 31 Dec 2023: revenue $124.6M, net income $9.6MQuarter to 31 Mar 2024: revenue $137.9M, net income $6.9MQuarter to 31 Mar 2024: revenue $137.9M, net income $6.9MQuarter to 30 Jun 2024: revenue $144.3M, net income $12.6MQuarter to 30 Jun 2024: revenue $144.3M, net income $12.6MQuarter to 30 Sep 2024: revenue $109.4M, net income $3.7MQuarter to 30 Sep 2024: revenue $109.4M, net income $3.7MQuarter to 31 Dec 2024: revenue $176.0M, net income $13.0MQuarter to 31 Dec 2024: revenue $176.0M, net income $13.0MQuarter to 31 Mar 2025: revenue $130.1M, net income $9.2MQuarter to 31 Mar 2025: revenue $130.1M, net income $9.2MQuarter to 30 Jun 2025: revenue $157.1M, net income $12.2MQuarter to 30 Jun 2025: revenue $157.1M, net income $12.2MQuarter to 30 Sep 2025: revenue $155.9M, net income $10.9MQuarter to 30 Sep 2025: revenue $155.9M, net income $10.9MQuarter to 31 Dec 2025: revenue $167.2M, net income $11.7MQuarter to 31 Dec 2025: revenue $167.2M, net income $11.7MQuarter to 31 Mar 2026: revenue $155.4M, net income $2.0MQuarter to 31 Mar 2026: revenue $155.4M, net income $2.0MQuarter to 30 Jun 2026: revenue $207.1M, net income $11.4MQuarter to 30 Jun 2026: revenue $207.1M, net income $11.4MQuarter to 30 Sep 2026: revenue $202.9M, net income $16.0MQuarter to 30 Sep 2026: revenue $202.9M, net income $16.0M
31 Dec 2021RevenueNet incomeNet losstallest bar $207.1M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$202.9M$16.0M
30 Jun 2026$207.1M$11.4M
31 Mar 2026$155.4M$2.0M
31 Dec 2025$167.2M$11.7M
30 Sep 2025$155.9M$10.9M
30 Jun 2025$157.1M$12.2M
31 Mar 2025$130.1M$9.2M
31 Dec 2024$176.0M$13.0M
30 Sep 2024$109.4M$3.7M
30 Jun 2024$144.3M$12.6M
31 Mar 2024$137.9M$6.9M
31 Dec 2023$124.6M$9.6M
30 Sep 2023$125.1M$11.1M
30 Jun 2023$121.1M$11.0M
31 Mar 2023$111.7M$7.0M
31 Dec 2022$123.6M$6.6M
30 Sep 2022$111.6M$4.9M
30 Jun 2022$118.2M$4.4M
31 Mar 2022$104.4M-$10.2M
31 Dec 2021$103.5M$4.3M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $732.7M $619.1M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +18% +8.1%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $41.1M $45.4M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $0.91 $1.12
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 42.0% 42.7% 61.3%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 10.7% 12.3% 5.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 5.6% 7.3% -2.7%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 11.6% -20.0%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $76.4M $61.3M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $63.9M $150.9M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.22
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $8.55
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 30.8 27.5
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.7 2.6
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 3.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 3.4 3.4
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 0.32% 1.6%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
CadreCDRE (this company) $1.3B30.81.7+18%5.6%
EnovisENOV $1.5Bloss0.64+3.3%-22.9%
Establishment LabsESTA $2.1Bloss7.8+38%-14.6%
Anteris Technologies GlobalAVR $486.5Mloss209+9.0%–
Sanara MedTechSMTI $298.9Mloss2.7+9.8%-2.7%
Mine SafetyMSA $6.5B21.63.3+8.1%15.0%

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+30%

$202.9M vs $155.9M (quarter ended 30 Sep 2026)

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$6.5M

bought $0, sold $6.5M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+17%

180 13F filers vs 154

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

76%

32.5M shares held by 13F filers (30 Sep 2026) of 42.9M outstanding (30 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

5.0%

2.1M shares sold short (30 Oct 2026) of 42.9M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.5

2.1M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+14%

1.9M shares sold short in the report before, 2.1M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

56%

56% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 59%

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$22.3M

the 12 months before: $78K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$20K

4 quarters

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

22

22 articles in the last 7 days; its usual week has 3 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

7.3×

22 articles in the last 7 days; its usual week has 3.

Price $29.45 on 20 Nov 2026, -25% over 12 months (12-month range $24.55 to $46.07)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $26.3M in the last 12 months (the 12 months before: -$100.2M).
Revenue per quarter. Revenue $202.9M in the latest quarter, +30% on a year earlier.
Capital spending per quarter. Capital spending $3.1M in the latest quarter, +262% on a year earlier.
Institutional holders (13F filers). 180 13F filers reported holding it in the latest 13F quarter, +26% on a year earlier.
Federal obligations. Federal obligations: $22.3M published in the last 12 months, +79363% on the 12 months before.
Lobbying spend. Lobbying spend: $20K published in the last 12 months (none in the 12 months before).

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
16 Nov 20268-K and other filingsCFO Blaine Browers resigned, effective Dec 31, 2026; Chad Appleby appointed interim CFO
16 Nov 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Aug 2026Sharp changeShort interest spike: short interest spike, 3.1M vs usual 2.0M (2026-07-31); 1.4x the same period a year earlier
6 Aug 2026Sharp changeQuarterly revenue change: quarterly revenue change, 207.1M vs usual 155.6M (2026-06-30); 1.3x the same period a year earlier
3 Jun 20268-K and other filingsDirector or officer change
3 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
5 Jun 20258-K and other filingsDirector or officer change
5 Jun 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Mar 2025Sharp changeQuarterly revenue change: quarterly revenue change, 176.0M vs usual 124.1M (2024-12-31); 1.4x the same period a year earlier
27 Jan 20258-K and other filingsDirector or officer change
15 Jan 20258-K and other filingsDirector or officer change
15 Jan 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Jul 2024Sharp changeShort interest spike: short interest spike, 1.8M vs usual 759K (2024-07-15); 3.5x the same period a year earlier
28 May 2024Sharp changeShort interest spike: short interest spike, 1.2M vs usual 648K (2024-05-15); 2.1x the same period a year earlier
21 May 2024Sharp changeMany funds opening a new position: many funds opening a new position, 47 vs usual 10.50 (2024-03-31); 5.9x the same period a year earlier
8 Jun 20228-K and other filingsRegistered new securities for sale (S-1)
7 Jun 20228-K and other filingsRegistered new securities for sale (S-1)
5 May 20228-K and other filingsCompleted an acquisition or asset sale
14 Apr 20228-K and other filingsDirector or officer change
14 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
5 Jan 20228-K and other filingsRegistered new securities for sale (S-1)
3 Jan 20228-K and other filingsRegistered new securities for sale (S-1)
22 Dec 20218-K and other filingsRegistered new securities for sale (S-1)
Insider net buying (open market)
Month from 1 Dec 2022: -$2.0M published
Month from 1 May 2023: -$256K published
Month from 1 Jun 2023: -$32.8M published
Month from 1 Aug 2023: -$1.4M published
Month from 1 Sep 2023: -$893K published
Month from 1 Nov 2023: -$2.4M published
Month from 1 Dec 2023: -$3.0M published
Month from 1 Mar 2024: -$50.3M published
Month from 1 Jun 2024: -$1.3M published
Month from 1 Aug 2024: -$2.1M published
Month from 1 Sep 2024: -$7.3M published
Month from 1 Nov 2024: -$10.2M published
Month from 1 Dec 2024: -$11.5M published
Month from 1 Mar 2025: -$14.6M published
Month from 1 May 2025: -$10.1M published
Month from 1 Jun 2025: -$10.0M published
Month from 1 Sep 2025: -$153K published
Month from 1 Oct 2025: -$343K published
Month from 1 Nov 2025: -$53.6M published
Month from 1 Dec 2025: -$1.9M published
Month from 1 Mar 2026: -$6.3M published
Month from 1 Jun 2026: -$8.6M published
Month from 1 Aug 2026: -$9.5M published
Revenue per quarter
Quarter ended 30 Sep 2020: $105.7M; public on 3 Dec 2021
Quarter ended 31 Dec 2020: $107.6M; public on 12 Mar 2022
Quarter ended 31 Mar 2021: $110.5M; public on 17 May 2022
Quarter ended 30 Jun 2021: $114.6M; public on 12 Aug 2022
Quarter ended 30 Sep 2021: $98.7M, -6.7% on a year earlier; public on 3 Dec 2021
Quarter ended 31 Dec 2021: $103.5M, -3.8% on a year earlier; public on 12 Mar 2022
Quarter ended 31 Mar 2022: $104.4M, -5.5% on a year earlier; public on 17 May 2022
Quarter ended 30 Jun 2022: $118.2M, +3.2% on a year earlier; public on 12 Aug 2022
Quarter ended 30 Sep 2022: $111.6M, +13% on a year earlier; public on 11 Nov 2022
Quarter ended 31 Dec 2022: $123.6M, +19% on a year earlier; public on 16 Mar 2023
Quarter ended 31 Mar 2023: $111.7M, +7.0% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $121.1M, +2.4% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $125.1M, +12% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $124.6M, +0.8% on a year earlier; public on 13 Mar 2024
Quarter ended 31 Mar 2024: $137.9M, +23% on a year earlier; public on 9 May 2024
Quarter ended 30 Jun 2024: $144.3M, +19% on a year earlier; public on 10 Aug 2024
Quarter ended 30 Sep 2024: $109.4M, -13% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $176.0M, +41% on a year earlier; public on 12 Mar 2025
Quarter ended 31 Mar 2025: $130.1M, -5.6% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $157.1M, +8.9% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $155.9M, +42% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $167.2M, -5.0% on a year earlier; public on 11 Mar 2026
Quarter ended 31 Mar 2026: $155.4M, +19% on a year earlier; public on 12 May 2026
Quarter ended 30 Jun 2026: $207.1M, +32% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $202.9M, +30% on a year earlier; public on 5 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2020: $795K; public on 12 Mar 2022
Quarter ended 31 Mar 2021: $788K; public on 17 May 2022
Quarter ended 30 Jun 2021: $718K; public on 12 Aug 2022
Quarter ended 30 Sep 2021: $719K; public on 3 Dec 2021
Quarter ended 31 Dec 2021: $607K, -24% on a year earlier; public on 12 Mar 2022
Quarter ended 31 Mar 2022: $950K, +21% on a year earlier; public on 17 May 2022
Quarter ended 30 Jun 2022: $1.5M, +112% on a year earlier; public on 12 Aug 2022
Quarter ended 30 Sep 2022: $465K, -35% on a year earlier; public on 11 Nov 2022
Quarter ended 31 Dec 2022: $1.6M, +156% on a year earlier; public on 16 Mar 2023
Quarter ended 31 Mar 2023: $781K, -18% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $1.6M, +6.6% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $1.8M, +297% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $2.5M, +59% on a year earlier; public on 13 Mar 2024
Quarter ended 31 Mar 2024: $1.3M, +72% on a year earlier; public on 9 May 2024
Quarter ended 30 Jun 2024: $2.0M, +25% on a year earlier; public on 10 Aug 2024
Quarter ended 30 Sep 2024: $1.0M, -45% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $1.3M, -48% on a year earlier; public on 12 Mar 2025
Quarter ended 31 Mar 2025: $1.3M, -2.5% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $1.4M, -30% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $849K, -16% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $3.3M, +154% on a year earlier; public on 11 Mar 2026
Quarter ended 31 Mar 2026: $2.7M, +105% on a year earlier; public on 12 May 2026
Quarter ended 30 Jun 2026: $3.5M, +142% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $3.1M, +262% on a year earlier; public on 5 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 39; public on 14 Feb 2022
31 Mar 2022 report: 47; public on 16 May 2022
30 Jun 2022 report: 69; public on 15 Aug 2022
30 Sep 2022 report: 67; public on 14 Nov 2022
31 Dec 2022 report: 71; public on 14 Feb 2023
31 Mar 2023 report: 76; public on 15 May 2023
30 Jun 2023 report: 67; public on 14 Aug 2023
30 Sep 2023 report: 75; public on 14 Nov 2023
31 Dec 2023 report: 97; public on 14 Feb 2024
31 Mar 2024 report: 137; public on 15 May 2024
30 Jun 2024 report: 123; public on 14 Aug 2024
30 Sep 2024 report: 123; public on 14 Nov 2024
31 Dec 2024 report: 139; public on 14 Feb 2025
31 Mar 2025 report: 152; public on 15 May 2025
30 Jun 2025 report: 157; public on 14 Aug 2025
30 Sep 2025 report: 143; public on 14 Nov 2025
31 Dec 2025 report: 160; public on 17 Feb 2026
31 Mar 2026 report: 166; public on 15 May 2026
30 Jun 2026 report: 154; public on 14 Aug 2026
30 Sep 2026 report: 180; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $5K published
Month from 1 Dec 2021: $4.5M published
Month from 1 Jan 2022: $0 published
Month from 1 Feb 2022: $5K published
Month from 1 Mar 2022: -$13.0 published
Month from 1 Apr 2022: $151K published
Month from 1 May 2022: $1.9M published
Month from 1 Jun 2022: $71K published
Month from 1 Jul 2022: $176K published
Month from 1 Aug 2022: $25K published
Month from 1 Sep 2022: $507K published
Month from 1 Oct 2022: $1.1M published
Month from 1 Nov 2022: $248 published
Month from 1 Dec 2022: $543K published
Month from 1 Jan 2023: $25K published
Month from 1 Apr 2023: $14K published
Month from 1 May 2023: $2.2M published
Month from 1 Jun 2023: $29K published
Month from 1 Jul 2023: $4K published
Month from 1 Aug 2023: $4K published
Month from 1 Sep 2023: $55K published
Month from 1 Oct 2023: $5K published
Month from 1 Nov 2023: $516K published
Month from 1 Dec 2023: $25K published
Month from 1 Jan 2024: -$3K published
Month from 1 Feb 2024: $149 published
Month from 1 Apr 2024: $2K published
Month from 1 May 2024: $201 published
Month from 1 Jul 2024: $34K published
Month from 1 Aug 2024: $5K published
Month from 1 Sep 2024: $46K published
Month from 1 Oct 2024: $6K published
Month from 1 Jan 2025: -$714 published
Month from 1 Aug 2025: $29K published
Month from 1 Dec 2025: $10.0M published
Month from 1 Feb 2026: $38K published
Month from 1 May 2026: -$0.0 published
Month from 1 Jun 2026: $0 published
Month from 1 Aug 2026: $8.4M published
Month from 1 Sep 2026: $187K published
Month from 1 Oct 2026: $3.6M published
Lobbying spend
Quarter from 1 Jan 2022: $20K published
Quarter from 1 Apr 2022: $20K published
Quarter from 1 Oct 2026: $20K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $6.5M (26 Aug 2026), 5.9× its normal reading; higher than 91% of its own history. Two or more unrelated kinds of activity agreed on 18 Aug 2026.
  • Short interest spike: had 3.1M shares sold short in the 31 Jul 2026 report, 1.4× the same report last year Public on 12 Aug 2026.
  • Quarterly revenue change: reported revenue of $207.1M for the quarter ended 30 Jun 2026, 1.3× the same quarter last year Public on 6 Aug 2026.
  • Insider net buying (open market): Insiders sold a net $26.3M in the last 12 months (the 12 months before: -$100.2M).

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 71 insider trades

Last 90 days: 1 sale, $6.5M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
26 Aug 2026Warren B KandersCEO AND CHAIRMANSell200,000$32.61$6.5MForm 4
19 Aug 2026Brad WilliamsPRESIDENTSellafter exercising options88,742$33.24$2.9MForm 4
23 Jun 2026Warren B KandersCEO AND CHAIRMANSell75,000$27.57$2.1MForm 4
17 Jun 2026Warren B KandersCEO AND CHAIRMANSell225,000$29.06$6.5MForm 4
24 Mar 2026Warren B KandersCEO AND CHAIRMANSell200,000$31.66$6.3MForm 4
16 Dec 2025Blaine BrowersCHIEF FINANCIAL OFFICERSell20,435$43.79$895KForm 4
12 Dec 2025Brad WilliamsPRESIDENTSell24,000$42.99$1.0MForm 4
19 Nov 2025Warren B KandersCEO AND CHAIRMANSell1,343,941$39.00$52.4MForm 4

180 institutions reported shares at the end of Q3 2026, 76% of the shares outstanding; 40 opened a position, 16 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.3.0M6.96%$74.9M+50K+1.7%
Greenhouse Funds LLLP2.9M6.64%$71.5M-17K-0.6%
FMR LLC (Fidelity)2.6M5.96%$64.2M+83K+3.3%
Reinhart Partners, LLC.2.3M5.33%$57.4M-451K-16%
State Street Corp1.4M3.29%$35.4M-538K-28%
Vanguard Capital Management LLC1.4M3.27%$35.3M+81K+6.1%
GW&K Investment Management, LLC1.3M3.06%+40K+3.2%
Wynnefield Capital Inc1.2M2.81%$30.2MNo change
Capital World Investors1.0M2.44%$26.3M-158K-13%
Select Equity Group, L.P.969K2.26%$24.3M-213K-18%

Federal contracts

All 20 federal contracts

2 new awards in 12 months, $12.0M obligated when signed. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
23 Jul 2026Department of DefenseU.S. Special Operations Command$3.6MBEMO KIT AND PARTS/REPLACEMENTSUSAspending
21 May 2026Department of DefenseU.S. Special Operations Command$8.4MBEMO KIT AND PARTS/REPLACEMENTSUSAspending
26 Sep 2025Department of DefenseU.S. Special Operations Command$10.0MBLAST EXPOSURE MONITORING (BEMO) SYSTEMS, ACCESSORIES AND REPLACEMENT PARTS, AND SOFTWARE MAINTENANCE.USAspending
24 Feb 2023Department of DefenseDepartment of the Air Force$2.2MBOMB SUIT ENSEMBLEUSAspending
19 Jul 2022Department of DefenseDepartment of the Air Force$1.0MEOD BOMB SUIT ORDER 10USAspending
9 Feb 2022Department of DefenseDepartment of the Air Force$1.8MEOD BOMB SUIT ORDER 9USAspending
28 Sep 2021Department of DefenseU.S. Special Operations Command$1.1MDELIVERY ORDER FOR MASS OVER-GARMENTSUSAspending
13 May 2021Department of DefenseDepartment of the Air Force$3.2MBOMB SUITS AND HELMETSUSAspending

Company events

All 30 company events

In 12 months: 2 director or officer changes, 1 major agreement. Results releases and routine reports are left out.

FiledWhat happenedSource
16 Nov 2026CFO Blaine Browers resigned, effective Dec 31, 2026; Chad Appleby appointed interim CFO8-K
29 Jul 2026Signed a major agreementSame filing: took on new debt8-K
3 Jun 2026Director or officer changeSame filing: shareholder vote results8-K
3 Nov 2025Signed a major agreement8-K
5 Jun 2025Director or officer changeSame filing: shareholder vote results8-K
27 Jan 2025Director or officer change; Signed a major agreement8-K
21 Jan 2025Signed a major agreement8-K
15 Jan 2025Director or officer change8-K

Reported lobbying spend: $20K in Q3 2026, $20K in Q1 2022. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Dec 2017EndedThe Advocacy Groupfor Pajarito Scientific CorporationNot statedFiling
1 Aug 2015NewThe Advocacy Groupfor Pajarito Scientific CorporationHR 3183 Energy & Water Appropriations, Title III, Provisions relating to nuclear enrichment.Trade, EnvironmentFiling
1 Jan 2015NewGhazal & Associates, LLCfor Safariland, LLCBulletproof Vest Partnership Grant Program.BudgetFiling

The 5 newest of 267 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

18 Aug 2026confirmed

Confirmed across sources Filings + Financials and Short interest and volume

Cadre (CDRE): reported revenue of $207.1M for the quarter ended 30 Jun 2026, 1.3× the same quarter last year, while it had 3.1M shares sold short in the 31 Jul 2026 report, 1.4× the same report last year. Two unrelated kinds of activity within 12 days.

  • Financials: Quarterly revenue change, became public on 6 Aug 2026
  • Short interest and volume: Short interest spike, became public on 12 Aug 2026
2024-06-30: $144.3M2024-09-30: $109.4M2024-12-31: $176.0M2025-03-31: $130.1M2025-06-30: $157.1M2025-09-30: $155.9M2025-12-31: $167.2M2026-03-31: $155.4M2026-06-30: $207.1M
The quarter ended 30 Jun 2026 against the 8 quarters before it. this quarterearliernormal: $155.6M
See the evidence (2 changes)

Financials: Quarterly revenue change became public on 6 Aug 2026

Cadre reported revenue of $207.1M for the quarter ended 30 Jun 2026, 1.3× the same quarter last year.

This period
$207.1M (the quarter ended 30 Jun 2026)
Normal quarter (median of 8 earlier)
$155.6M
Typical spread (median absolute deviation)
$11.5M
How far from its usual level
+3.0
Same quarter last year
$157.1M
History used
2,099 days
2024-06-30: $144.3M2024-09-30: $109.4M2024-12-31: $176.0M2025-03-31: $130.1M2025-06-30: $157.1M2025-09-30: $155.9M2025-12-31: $167.2M2026-03-31: $155.4M2026-06-30: $207.1M
the quarter ended 30 Jun 20268 earlier quartersnormal: $155.6M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Short interest and volume: Short interest spike became public on 12 Aug 2026

Cadre had 3.1M shares sold short in the 31 Jul 2026 report, 1.4× the same report last year.

This period
3.1M (the 31 Jul 2026 report)
Normal report (median of 24 earlier)
2.0M
Typical spread (median absolute deviation)
189K
How far from its usual level
+3.9
Same report last year
2.2M
History used
1,719 days
2025-07-31: 2.2M2025-08-15: 1.8M2025-08-29: 2.0M2025-09-15: 2.0M2025-09-30: 1.9M2025-10-15: 2.1M2025-10-31: 2.6M2025-11-14: 2.0M2025-11-28: 2.1M2025-12-15: 2.3M2025-12-31: 2.1M2026-01-15: 1.8M2026-01-30: 2.3M2026-02-13: 1.7M2026-02-27: 1.6M2026-03-13: 1.8M2026-03-31: 2.0M2026-04-15: 2.1M2026-04-30: 2.6M2026-05-15: 2.4M2026-05-29: 2.0M2026-06-15: 2.0M2026-06-30: 2.3M2026-07-15: 2.6M2026-07-31: 3.1M
the 31 Jul 2026 report24 earlier reportsnormal: 2.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

28 May 2024confirmed

Confirmed across sources Institutional holdings and Short interest and volume

Cadre (CDRE): saw 47 13F filers open a new position in the quarter ended 31 Mar 2024, 5.9× the same quarter last year, while it had 1.2M shares sold short in the 15 May 2024 report, 2.1× the same report last year. Two unrelated kinds of activity within 7 days.

  • Institutional holdings: Many funds opening a new position, became public on 15 May 2024
  • Short interest and volume: Short interest spike, became public on 25 May 2024
2022-03-31: 82022-06-30: 292022-09-30: 122022-12-31: 132023-03-31: 82023-06-30: 52023-09-30: 92023-12-31: 232024-03-31: 47
The quarter ended 31 Mar 2024 against the 8 quarters before it. this quarterearliernormal: 10.5
See the evidence (2 changes)

Institutional holdings: Many funds opening a new position became public on 15 May 2024

Cadre saw 47 13F filers open a new position in the quarter ended 31 Mar 2024, 5.9× the same quarter last year.

This period
47 (the quarter ended 31 Mar 2024)
Normal quarter (median of 8 earlier)
10.5
Typical spread (median absolute deviation)
2.5
How far from its usual level
+9.8
Same quarter last year
8
History used
821 days
2022-03-31: 82022-06-30: 292022-09-30: 122022-12-31: 132023-03-31: 82023-06-30: 52023-09-30: 92023-12-31: 232024-03-31: 47
the quarter ended 31 Mar 20248 earlier quartersnormal: 10.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 25 May 2024

Cadre had 1.2M shares sold short in the 15 May 2024 report, 2.1× the same report last year.

This period
1.2M (the 15 May 2024 report)
Normal report (median of 24 earlier)
648K
Typical spread (median absolute deviation)
112K
How far from its usual level
+3.6
Same report last year
607K
History used
912 days
2023-05-15: 607K2023-05-31: 541K2023-06-15: 498K2023-06-30: 537K2023-07-14: 507K2023-07-31: 545K2023-08-15: 552K2023-08-31: 644K2023-09-15: 761K2023-09-29: 888K2023-10-13: 905K2023-10-31: 752K2023-11-15: 652K2023-11-30: 498K2023-12-15: 380K2023-12-29: 573K2024-01-12: 573K2024-01-31: 758K2024-02-15: 735K2024-02-29: 788K2024-03-15: 919K2024-03-28: 1.1M2024-04-15: 1.1M2024-04-30: 994K2024-05-15: 1.2M
the 15 May 2024 report24 earlier reportsnormal: 648K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 16 Nov 2026Filings change

    filed a director or officer change: CFO Blaine Browers resigned, effective Dec 31, 2026; Chad Appleby appointed interim CFO.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 16 Nov 2026Filings record

    CFO Blaine Browers resigned, effective Dec 31, 2026; Chad Appleby appointed interim CFO

  3. 23 Oct 2026Government contracts record

    MED-ENG, LLC: new Department of Defense contract H9240326FE124 ($3.6M) (dated 23 Jul 2026)

  4. 21 Aug 2026Government contracts record

    MED-ENG, LLC: new Department of Defense contract H9240326FE069 ($8.4M) (dated 21 May 2026)

  5. 18 Aug 2026several at once

    reported revenue of $207.1M for the quarter ended 30 Jun 2026, 1.3× the same quarter last year, while it had 3.1M shares sold short in the 31 Jul 2026 report, 1.4× the same report last year. Two unrelated kinds of activity within 12 days.

    See the evidence (2 changes)

    Financials: Quarterly revenue change became public on 6 Aug 2026

    Cadre reported revenue of $207.1M for the quarter ended 30 Jun 2026, 1.3× the same quarter last year.

    This period
    $207.1M (the quarter ended 30 Jun 2026)
    Normal quarter (median of 8 earlier)
    $155.6M
    Typical spread (median absolute deviation)
    $11.5M
    How far from its usual level
    +3.0
    Same quarter last year
    $157.1M
    History used
    2,099 days
    2024-06-30: $144.3M2024-09-30: $109.4M2024-12-31: $176.0M2025-03-31: $130.1M2025-06-30: $157.1M2025-09-30: $155.9M2025-12-31: $167.2M2026-03-31: $155.4M2026-06-30: $207.1M
    the quarter ended 30 Jun 20268 earlier quartersnormal: $155.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Short interest and volume: Short interest spike became public on 12 Aug 2026

    Cadre had 3.1M shares sold short in the 31 Jul 2026 report, 1.4× the same report last year.

    This period
    3.1M (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    2.0M
    Typical spread (median absolute deviation)
    189K
    How far from its usual level
    +3.9
    Same report last year
    2.2M
    History used
    1,719 days
    2025-07-31: 2.2M2025-08-15: 1.8M2025-08-29: 2.0M2025-09-15: 2.0M2025-09-30: 1.9M2025-10-15: 2.1M2025-10-31: 2.6M2025-11-14: 2.0M2025-11-28: 2.1M2025-12-15: 2.3M2025-12-31: 2.1M2026-01-15: 1.8M2026-01-30: 2.3M2026-02-13: 1.7M2026-02-27: 1.6M2026-03-13: 1.8M2026-03-31: 2.0M2026-04-15: 2.1M2026-04-30: 2.6M2026-05-15: 2.4M2026-05-29: 2.0M2026-06-15: 2.0M2026-06-30: 2.3M2026-07-15: 2.6M2026-07-31: 3.1M
    the 31 Jul 2026 report24 earlier reportsnormal: 2.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  6. 12 Aug 2026Short interest and volume change

    had 3.1M shares sold short in the 31 Jul 2026 report, 1.4× the same report last year.

    Same report last year: 2.2M; its normal report is 2.0M.

    See the evidence
    This period
    3.1M (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    2.0M
    Typical spread (median absolute deviation)
    189K
    How far from its usual level
    +3.9
    Same report last year
    2.2M
    History used
    1,719 days
    2025-07-31: 2.2M2025-08-15: 1.8M2025-08-29: 2.0M2025-09-15: 2.0M2025-09-30: 1.9M2025-10-15: 2.1M2025-10-31: 2.6M2025-11-14: 2.0M2025-11-28: 2.1M2025-12-15: 2.3M2025-12-31: 2.1M2026-01-15: 1.8M2026-01-30: 2.3M2026-02-13: 1.7M2026-02-27: 1.6M2026-03-13: 1.8M2026-03-31: 2.0M2026-04-15: 2.1M2026-04-30: 2.6M2026-05-15: 2.4M2026-05-29: 2.0M2026-06-15: 2.0M2026-06-30: 2.3M2026-07-15: 2.6M2026-07-31: 3.1M
    the 31 Jul 2026 report24 earlier reportsnormal: 2.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 6 Aug 2026Financials change

    reported revenue of $207.1M for the quarter ended 30 Jun 2026, 1.3× the same quarter last year.

    Same quarter last year: $157.1M; its normal quarter is $155.6M.

    See the evidence
    This period
    $207.1M (the quarter ended 30 Jun 2026)
    Normal quarter (median of 8 earlier)
    $155.6M
    Typical spread (median absolute deviation)
    $11.5M
    How far from its usual level
    +3.0
    Same quarter last year
    $157.1M
    History used
    2,099 days
    2024-06-30: $144.3M2024-09-30: $109.4M2024-12-31: $176.0M2025-03-31: $130.1M2025-06-30: $157.1M2025-09-30: $155.9M2025-12-31: $167.2M2026-03-31: $155.4M2026-06-30: $207.1M
    the quarter ended 30 Jun 20268 earlier quartersnormal: $155.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  8. 3 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  9. 3 Jun 2026Filings record

    Director or officer change

  10. 27 Dec 2025Government contracts record

    MED-ENG, LLC: new Department of Defense contract H9240325FE058 ($10.0M) (dated 26 Sep 2025)

  11. 5 Jun 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 5 Jun 2025Filings record

    Director or officer change

  13. 18 Mar 2025Financials change

    reported revenue of $176.0M for the quarter ended 31 Dec 2024, 1.4× the same quarter last year.

    Same quarter last year: $124.6M; its normal quarter is $124.1M.

    See the evidence
    This period
    $176.0M (the quarter ended 31 Dec 2024)
    Normal quarter (median of 8 earlier)
    $124.1M
    Typical spread (median absolute deviation)
    $7.7M
    How far from its usual level
    +4.2
    Same quarter last year
    $124.6M
    History used
    1,553 days
    2022-12-31: $123.6M2023-03-31: $111.7M2023-06-30: $121.1M2023-09-30: $125.1M2023-12-31: $124.6M2024-03-31: $137.9M2024-06-30: $144.3M2024-09-30: $109.4M2024-12-31: $176.0M
    the quarter ended 31 Dec 20248 earlier quartersnormal: $124.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  14. 27 Jan 2025Filings record

    Director or officer change

  15. 15 Jan 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  16. 15 Jan 2025Filings record

    Director or officer change

  17. 25 Jul 2024Short interest and volume change

    had 1.8M shares sold short in the 15 Jul 2024 report, 3.5× the same report last year.

    Same report last year: 507K; its normal report is 759K.

    See the evidence
    This period
    1.8M (the 15 Jul 2024 report)
    Normal report (median of 24 earlier)
    759K
    Typical spread (median absolute deviation)
    197K
    How far from its usual level
    +3.5
    Same report last year
    507K
    History used
    973 days
    2023-07-14: 507K2023-07-31: 545K2023-08-15: 552K2023-08-31: 644K2023-09-15: 761K2023-09-29: 888K2023-10-13: 905K2023-10-31: 752K2023-11-15: 652K2023-11-30: 498K2023-12-15: 380K2023-12-29: 573K2024-01-12: 573K2024-01-31: 758K2024-02-15: 735K2024-02-29: 788K2024-03-15: 919K2024-03-28: 1.1M2024-04-15: 1.1M2024-04-30: 994K2024-05-15: 1.2M2024-05-31: 1.1M2024-06-14: 1.3M2024-06-28: 1.4M2024-07-15: 1.8M
    the 15 Jul 2024 report24 earlier reportsnormal: 759K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 28 May 2024several at once

    saw 47 13F filers open a new position in the quarter ended 31 Mar 2024, 5.9× the same quarter last year, while it had 1.2M shares sold short in the 15 May 2024 report, 2.1× the same report last year. Two unrelated kinds of activity within 7 days.

    See the evidence (2 changes)

    Institutional holdings: Many funds opening a new position became public on 15 May 2024

    Cadre saw 47 13F filers open a new position in the quarter ended 31 Mar 2024, 5.9× the same quarter last year.

    This period
    47 (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    10.5
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +9.8
    Same quarter last year
    8
    History used
    821 days
    2022-03-31: 82022-06-30: 292022-09-30: 122022-12-31: 132023-03-31: 82023-06-30: 52023-09-30: 92023-12-31: 232024-03-31: 47
    the quarter ended 31 Mar 20248 earlier quartersnormal: 10.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 25 May 2024

    Cadre had 1.2M shares sold short in the 15 May 2024 report, 2.1× the same report last year.

    This period
    1.2M (the 15 May 2024 report)
    Normal report (median of 24 earlier)
    648K
    Typical spread (median absolute deviation)
    112K
    How far from its usual level
    +3.6
    Same report last year
    607K
    History used
    912 days
    2023-05-15: 607K2023-05-31: 541K2023-06-15: 498K2023-06-30: 537K2023-07-14: 507K2023-07-31: 545K2023-08-15: 552K2023-08-31: 644K2023-09-15: 761K2023-09-29: 888K2023-10-13: 905K2023-10-31: 752K2023-11-15: 652K2023-11-30: 498K2023-12-15: 380K2023-12-29: 573K2024-01-12: 573K2024-01-31: 758K2024-02-15: 735K2024-02-29: 788K2024-03-15: 919K2024-03-28: 1.1M2024-04-15: 1.1M2024-04-30: 994K2024-05-15: 1.2M
    the 15 May 2024 report24 earlier reportsnormal: 648K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  19. 25 May 2024Short interest and volume change

    had 1.2M shares sold short in the 15 May 2024 report, 2.1× the same report last year.

    Same report last year: 607K; its normal report is 648K.

    See the evidence
    This period
    1.2M (the 15 May 2024 report)
    Normal report (median of 24 earlier)
    648K
    Typical spread (median absolute deviation)
    112K
    How far from its usual level
    +3.6
    Same report last year
    607K
    History used
    912 days
    2023-05-15: 607K2023-05-31: 541K2023-06-15: 498K2023-06-30: 537K2023-07-14: 507K2023-07-31: 545K2023-08-15: 552K2023-08-31: 644K2023-09-15: 761K2023-09-29: 888K2023-10-13: 905K2023-10-31: 752K2023-11-15: 652K2023-11-30: 498K2023-12-15: 380K2023-12-29: 573K2024-01-12: 573K2024-01-31: 758K2024-02-15: 735K2024-02-29: 788K2024-03-15: 919K2024-03-28: 1.1M2024-04-15: 1.1M2024-04-30: 994K2024-05-15: 1.2M
    the 15 May 2024 report24 earlier reportsnormal: 648K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 15 May 2024Institutional holdings change

    saw 47 13F filers open a new position in the quarter ended 31 Mar 2024, 5.9× the same quarter last year.

    Same quarter last year: 8; its normal quarter is 10.5.

    See the evidence
    This period
    47 (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    10.5
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +9.8
    Same quarter last year
    8
    History used
    821 days
    2022-03-31: 82022-06-30: 292022-09-30: 122022-12-31: 132023-03-31: 82023-06-30: 52023-09-30: 92023-12-31: 232024-03-31: 47
    the quarter ended 31 Mar 20248 earlier quartersnormal: 10.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  21. 27 May 2023Government contracts record

    MED-ENG, LLC: new Department of Defense contract FA805123F0011 ($2.2M) (dated 24 Feb 2023)

  22. 19 Oct 2022Government contracts record

    MED-ENG, LLC: new Department of Defense contract FA805122F0026 ($1.0M) (dated 19 Jul 2022)

  23. 8 Jun 2022Filings record

    Registered new securities for sale (S-1)

  24. 7 Jun 2022Filings record

    Registered new securities for sale (S-1)

  25. 12 May 2022Government contracts record

    MED-ENG, LLC: new Department of Defense contract FA805122F0012 ($1.8M) (dated 9 Feb 2022)

  26. 5 May 2022Filings record

    Completed an acquisition or asset sale

  27. 14 Apr 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 14 Apr 2022Filings record

    Director or officer change

  29. 5 Jan 2022Filings record

    Registered new securities for sale (S-1)

  30. 3 Jan 2022Filings record

    Registered new securities for sale (S-1)

  31. 29 Dec 2021Government contracts record

    MUSTANG SURVIVAL MFG, INC.: new Department of Defense contract H9240321F0095 ($1.1M) (dated 28 Sep 2021)

  32. 22 Dec 2021Filings record

    Registered new securities for sale (S-1)

  33. 1 Nov 2021Filings record

    Registered new securities for sale (S-1)

  34. 28 Oct 2021Filings record

    Registered new securities for sale (S-1)

  35. 10 Sep 2021Filings record

    Registered new securities for sale (S-1)

  36. 13 Aug 2021Government contracts record

    MED-ENG, LLC: new Department of Defense contract FA805121F0023 ($3.2M) (dated 13 May 2021)

  37. 2 Aug 2021Filings record

    Registered new securities for sale (S-1)

  38. 27 Jul 2021Filings record

    Registered new securities for sale (S-1)

  39. 12 Jul 2021Filings record

    Registered new securities for sale (S-1)

  40. 4 Dec 2020Government contracts record

    MED-ENG, LLC: new Department of Defense contract W91CRB20F0437 ($3.0M) (dated 3 Sep 2020)

Showing the newest 40 of 54 entries; narrow the window or the kind of data to see older ones.

Not listed: 127 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001860543
Ticker
CDRE
Domain
cadre-holdings.com
Hq location
FL|JACKSONVILLE|32218 (1 unverified)
Lobbying client
pajarito scientific
Name
Alpha Safety Intermediate, LLC, Atlantic Tactical, Inc, Bendalls Engineering Limited, Cadre Holdings, Inc. and 38 more
Uei
ML28DU1R7P77
  • Federal lobbying disclosures (LDA)3 records, 90 data points1 Jan 2015 to 30 Sep 2026
  • SEC Form 13F institutional holdings180 data points31 Dec 2021 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)74 records12 Jul 2021 to 16 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)470 data points31 Dec 2019 to 30 Oct 2026
  • SEC Form 4 insider transactions71 records, 276 data points9 Dec 2022 to 26 Aug 2026
  • FINRA short interest (twice monthly)356 data points15 Nov 2021 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2534 data points4 Nov 2021 to 20 Nov 2026
  • USASpending.gov federal awards20 records, 3009 data points21 Mar 2013 to 4 Sep 2026